Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Bioinformatic Prediction of Possible Targets and Mechanisms of Action of the Green Tea Compound Epigallocatechin-3-Gallate Against Breast Cancer.

Song X, Zhang M, Chen L, Lin Q.

Front Mol Biosci. 2017 Jun 30;4:43. doi: 10.3389/fmolb.2017.00043. eCollection 2017.

2.

Suppressive Effects of Tea Catechins on Breast Cancer.

Xiang LP, Wang A, Ye JH, Zheng XQ, Polito CA, Lu JL, Li QS, Liang YR.

Nutrients. 2016 Jul 28;8(8). pii: E458. doi: 10.3390/nu8080458. Review.

3.

Tea consumption and risk of gallbladder cancer: A meta-analysis of epidemiological studies.

Zhu G, Hua J, Wang Z, She F, Chen Y.

Mol Clin Oncol. 2015 May;3(3):613-618. Epub 2015 Jan 21.

4.

Tea and human health: biomedical functions of tea active components and current issues.

Chen ZM, Lin Z.

J Zhejiang Univ Sci B. 2015 Feb;16(2):87-102. doi: 10.1631/jzus.B1500001. Review.

5.

Green tea compounds in breast cancer prevention and treatment.

Li MJ, Yin YC, Wang J, Jiang YF.

World J Clin Oncol. 2014 Aug 10;5(3):520-8. doi: 10.5306/wjco.v5.i3.520. Review.

6.

Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.

Kumar N, Chornokur G.

Transl Med (Sunnyvale). 2012 Dec 31;Suppl 2:005.

7.

Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.

Kim SJ, Amankwah E, Connors S, Park HY, Rincon M, Cornnell H, Chornokur G, Hashim AI, Choi J, Tsai YY, Engelman RW, Kumar N, Park JY.

Cancer Prev Res (Phila). 2014 Apr;7(4):435-44. doi: 10.1158/1940-6207.CAPR-13-0427-T. Epub 2014 Feb 5.

8.

Going Green: The Role of the Green Tea Component EGCG in Chemoprevention.

Schramm L.

J Carcinog Mutagen. 2013 May 20;4(142):1000142.

9.

Cancer incidence trends among Asian American populations in the United States, 1990-2008.

Gomez SL, Noone AM, Lichtensztajn DY, Scoppa S, Gibson JT, Liu L, Morris C, Kwong S, Fish K, Wilkens LR, Goodman MT, Deapen D, Miller BA.

J Natl Cancer Inst. 2013 Aug 7;105(15):1096-110. doi: 10.1093/jnci/djt157. Epub 2013 Jul 22.

10.

Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy.

Liao GS, Apaya MK, Shyur LF.

Evid Based Complement Alternat Med. 2013;2013:437948. doi: 10.1155/2013/437948. Epub 2013 Jun 12.

11.

Black tea, green tea and risk of breast cancer: an update.

Wu Y, Zhang D, Kang S.

Springerplus. 2013 May 24;2(1):240. doi: 10.1186/2193-1801-2-240. Print 2013 Dec.

12.

Overview of major classes of plant-derived anticancer drugs.

Amin A, Gali-Muhtasib H, Ocker M, Schneider-Stock R.

Int J Biomed Sci. 2009 Mar;5(1):1-11.

13.

EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression.

Gu JW, Makey KL, Tucker KB, Chinchar E, Mao X, Pei I, Thomas EY, Miele L.

Vasc Cell. 2013 May 2;5(1):9. doi: 10.1186/2045-824X-5-9.

14.

Coffee consumption and risk of breast cancer: an up-to-date meta-analysis.

Li XJ, Ren ZJ, Qin JW, Zhao JH, Tang JH, Ji MH, Wu JZ.

PLoS One. 2013;8(1):e52681. doi: 10.1371/journal.pone.0052681. Epub 2013 Jan 4.

15.

Green tea drinking and subsequent risk of breast cancer in a population-based cohort of Japanese women.

Iwasaki M, Inoue M, Sasazuki S, Sawada N, Yamaji T, Shimazu T, Willett WC, Tsugane S; Japan Public Health Center-Based Prospective Study Group.

Breast Cancer Res. 2010;12(5):R88. doi: 10.1186/bcr2756. Epub 2010 Oct 28.

16.

Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer.

Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C, McArthur HL, Chang J, Rimawi M, Vornik L, Cornelison TL, Wang A, Hibshoosh H, Ahmed A, Terry MB, Santella RM, Lippman SM, Hershman DL.

Cancer Prev Res (Phila). 2012 Sep;5(9):1144-54. doi: 10.1158/1940-6207.CAPR-12-0117. Epub 2012 Jul 24.

17.

Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy.

Zhang G, Wang Y, Zhang Y, Wan X, Li J, Liu K, Wang F, Liu K, Liu Q, Yang C, Yu P, Huang Y, Wang S, Jiang P, Qu Z, Luan J, Duan H, Zhang L, Hou A, Jin S, Hsieh TC, Wu E.

Curr Mol Med. 2012 Feb;12(2):163-76.

18.

A tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor.

Li G, Lin W, Araya JJ, Chen T, Timmermann BN, Guo GL.

Toxicol Appl Pharmacol. 2012 Jan 15;258(2):268-74. doi: 10.1016/j.taap.2011.11.006. Epub 2011 Dec 4.

19.

Green Tea Polyphenols in drug discovery - a success or failure?

Smith TJ.

Expert Opin Drug Discov. 2011 Jun;6(6):589-595.

20.

Green tea and breast cancer.

Wu AH, Butler LM.

Mol Nutr Food Res. 2011 Jun;55(6):921-30. doi: 10.1002/mnfr.201100006. Epub 2011 Apr 29. Review.

Supplemental Content

Support Center